Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Pharmacokinetics and safety of human recombinant hepatocyte growth factor administered to vocal folds.

Mizuta M, Hirano S, Kishimoto Y, Hiwatashi N, Tateya I, Kanemaru S, Nakamura T, Ito J.

Laryngoscope. 2014 Sep;124(9):2131-5. doi: 10.1002/lary.24690. Epub 2014 May 7.

PMID:
24668496
2.

Restoration of scarred vocal folds using 5 amino acid-deleted type hepatocyte growth factor.

Mizuta M, Hirano S, Ohno S, Kanemaru S, Nakamura T, Ito J.

Laryngoscope. 2014 Mar;124(3):E81-6. doi: 10.1002/lary.24413. Epub 2013 Oct 22.

PMID:
24115162
3.

Chronic vocal fold scar restoration with hepatocyte growth factor hydrogel.

Kishimoto Y, Hirano S, Kitani Y, Suehiro A, Umeda H, Tateya I, Kanemaru S, Tabata Y, Ito J.

Laryngoscope. 2010 Jan;120(1):108-13. doi: 10.1002/lary.20642.

PMID:
19877197
4.

Effect of exogenous hepatocyte growth factor on vocal fold fibroblasts.

Kishimoto Y, Hirano S, Suehiro A, Tateya I, Kanemaru S, Nakamura T, Ito J.

Ann Otol Rhinol Laryngol. 2009 Aug;118(8):606-11.

PMID:
19746761
5.

Optimal concentration of hepatocyte growth factor for treatment of the aged rat vocal fold.

Suehiro A, Wright H, Rousseau B.

Laryngoscope. 2011 Aug;121(8):1726-34. doi: 10.1002/lary.21816.

6.

Effects of hepatocyte growth factor injection and reinjection on healing in the rabbit vocal fold.

Dias Garcia RI, Tsuji DH, Imamura R, Mauad T, Ferraz da Silva LF.

J Voice. 2012 Sep;26(5):667.e7-12. doi: 10.1016/j.jvoice.2011.08.007. Epub 2012 Jan 31.

PMID:
22296997
7.

Hepatocyte growth factor and its receptor c-met in rat and rabbit vocal folds.

Hirano S, Thibeault S, Bless DM, Ford CN, Kanemaru S.

Ann Otol Rhinol Laryngol. 2002 Aug;111(8):661-6.

PMID:
12184584
8.

Drug delivery system of hepatocyte growth factor for the treatment of vocal fold scarring in a canine model.

Ohno T, Hirano S, Kanemaru S, Yamashita M, Umeda H, Suehiro A, Tamura Y, Nakamura T, Ito J, Tabata Y.

Ann Otol Rhinol Laryngol. 2007 Oct;116(10):762-9.

PMID:
17987782
9.

Regeneration of aged rat vocal folds using hepatocyte growth factor therapy.

Ohno T, Yoo MJ, Swanson ER, Hirano S, Ossoff RH, Rousseau B.

Laryngoscope. 2009 Jul;119(7):1424-30. doi: 10.1002/lary.20497.

10.

Prevention of vocal fold scarring by topical injection of hepatocyte growth factor in a rabbit model.

Hirano S, Bless DM, Rousseau B, Welham N, Montequin D, Chan RW, Ford CN.

Laryngoscope. 2004 Mar;114(3):548-56.

PMID:
15091233
11.

Growth factor therapy for vocal fold scarring in a canine model.

Hirano S, Bless DM, Nagai H, Rousseau B, Welham NV, Montequin DW, Ford CN.

Ann Otol Rhinol Laryngol. 2004 Oct;113(10):777-85.

PMID:
15535139
12.

Effect of AST on age-associated changes of vocal folds in a rat model.

Mizuta M, Hirano S, Hiwatashi N, Kobayashi T, Tateya I, Kanemaru S, Nakamura T, Ito J.

Laryngoscope. 2014 Oct;124(10):E411-7. doi: 10.1002/lary.24733. Epub 2014 May 27.

13.
14.

Controlled release of hepatocyte growth factor from a bovine acellular scaffold for vocal fold reconstruction.

Xu CC, Chan RW, Weinberger DG, Efune G, Pawlowski KS.

J Biomed Mater Res A. 2010 Jun 15;93(4):1335-47. doi: 10.1002/jbm.a.32632.

15.

The effects of decorin and HGF-primed vocal fold fibroblasts in vitro and ex vivo in a porcine model of vocal fold scarring.

Krishna P, Regner M, Palko J, Liu F, Abramowitch S, Jiang J, Wells A.

Laryngoscope. 2010 Nov;120(11):2247-57. doi: 10.1002/lary.21087.

16.

Pharmacokinetics and pharmacodynamics following intravenous administration of recombinant human hepatocyte growth factor in rats with renal injury.

Adachi E, Hirose-Sugiura T, Kato Y, Ikebuchi F, Yamashita A, Abe T, Fukuta K, Adachi K, Matsumoto K.

Pharmacology. 2014;94(3-4):190-7. doi: 10.1159/000363412. Epub 2014 Oct 31.

PMID:
25378205
17.

Safety and pharmacokinetics of recombinant human hepatocyte growth factor (rh-HGF) in patients with fulminant hepatitis: a phase I/II clinical trial, following preclinical studies to ensure safety.

Ido A, Moriuchi A, Numata M, Murayama T, Teramukai S, Marusawa H, Yamaji N, Setoyama H, Kim ID, Chiba T, Higuchi S, Yokode M, Fukushima M, Shimizu A, Tsubouchi H.

J Transl Med. 2011 May 8;9:55. doi: 10.1186/1479-5876-9-55.

18.

Gene expression of transforming growth factor-beta1 and hepatocyte growth factor during wound healing of injured rat vocal fold.

Ohno T, Hirano S, Rousseau B.

Laryngoscope. 2009 Apr;119(4):806-10. doi: 10.1002/lary.20174.

PMID:
19213039
19.

Role of circulating MSCs in vocal fold wound healing.

Ohno S, Hirano S, Kanemaru S, Mizuta M, Ishikawa S, Tateya I, Nakamura T, Ito J.

Laryngoscope. 2012 Nov;122(11):2503-10. doi: 10.1002/lary.23543. Epub 2012 Sep 10.

PMID:
22965435
20.

Prevention of vocal fold scarring by local application of basic fibroblast growth factor in a rat vocal fold injury model.

Suzuki R, Kawai Y, Tsuji T, Hiwatashi N, Kishimoto Y, Tateya I, Nakamura T, Hirano S.

Laryngoscope. 2017 Feb;127(2):E67-E74. doi: 10.1002/lary.26138. Epub 2016 Jul 14.

PMID:
27411786

Supplemental Content

Support Center